Schmid Timothy
EVP, WW Chair, MedTech
Schmid Timothy has filed 4 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Schmid Timothy is listed as EVP, WW Chair, MedTech at JOHNSON & JOHNSON. Inside the rolling window, Schmid Timothy reported no open-market purchases and 3 open-market sales totaling $15.1M in JNJ. The largest disclosed transaction in the window is a sale of 33,597 JNJ shares on Sep 2, 2026, worth $9.2M.
Companies traded
Other insiders at JNJ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$15.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Schmid Timothy made?
Schmid Timothy has filed 4 SEC Form 4 filings (19 transaction rows) across 1 company since 2026.
Which companies does Schmid Timothy trade?
Schmid Timothy has filed SEC Form 4 disclosures for 1 company, including JNJ.
When was Schmid Timothy's most recent SEC Form 4 filing?
Schmid Timothy's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Schmid Timothy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Schmid Timothy is listed as EVP, WW Chair, MedTech.
What is Schmid Timothy's total buy and sell value in the current window?
Inside the rolling retention window, Schmid Timothy bought $0 and sold $15.1M based on SEC Form 4 filings.
What was Schmid Timothy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 33,597 JNJ shares on 2026-09-02, worth $9.2M, per SEC Form 4 filings.